Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Liquidia Technologies IncLQDA · Entity 145051 | President and CFO | February 22, 2019 | February 23, 2019 |
| Progyny, Inc.PGNY · Entity 4521 | Director | September 10, 2026 | September 18, 2026 |
| VERACYTE, INC.VCYT · Entity 2018 | Director | June 08, 2022 | June 10, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Liquidia Technologies Inc
Report date February 22, 2019 · Filed February 23, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 162,915 |
Reported balance
After 2019-02-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-02-22 · Sale · Disposed 293 · Balance 162,915 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2018. F2: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.52 to $16.21, inclusive. The reporting person undertakes to provide to Liquidia Technologies, Inc., any holder of Liquidia Technologies, Inc. stock or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4. F3: Includes (i) 2,364 former restricted stock units ("RSUs") which settled into common stock on February 22, 2019 on a net basis following the sales of an aggregate of 293 shares of common stock to cover estimated taxes, transaction costs and fees associated with the vesting event, (ii) 20,572 former RSUs which settled into common stock on January 22, 2019 on a net basis following the sales of an aggregate of 11,322 shares of common stock to cover estimated taxes, transaction costs and fees associated with the vesting event, (iii) 93,025 remaining RSUs granted on January 22, 2018, which shall be settled into common stock in 36 equal monthly installments commencing January 22, 2019, subject to Mr. Gordon's continuous service as of each such date; F4: (iv) 41,084 RSUs granted on July 25, 2018, which shall be settled into common stock pursuant to the following vesting schedule: 25% of the RSUs shall vest on July 25, 2019, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Gordon's continuous service as of each such date; and (v) 5,870 RSUs granted on October 12, 2018 which shall be settled into common stock pursuant to the following vesting schedule: 25% of the RSUs shall vest on August 14, 2019, with the remaining 75% of such RSUs vesting in 36 equal monthly installments thereafter, subject to Mr. Gordon's continuous service as of each such date. |
| Common StockSEC Table I · non-derivative | Direct | 162,703 |
Reported balance
After 2019-02-22 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2019-02-22 · Sale · Disposed 212 · Balance 162,703 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2018. F5: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.82 to $16.84, inclusive. The reporting person undertakes to provide to Liquidia Technologies, Inc., any holder of Liquidia Technologies, Inc. stock or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 5 to this Form 4. F6: Includes (i) 2,152 former RSUs which settled into common stock on February 22, 2019 on a net basis following the sales of an aggregate of 505 shares of common stock (inclusive of the 293 shares which were sold as described in footnotes 3 and 4) to cover estimated taxes, transaction costs and fees associated with the vesting event, (ii) 20,572 former RSUs which settled into common stock on January 22, 2019 on a net basis following the sales of an aggregate of 11,322 shares of common stock to cover estimated taxes, transaction costs and fees associated with the vesting event, (iii) 93,025 remaining RSUs granted on January 22, 2018, which shall be settled into common stock in 36 equal monthly installments commencing January 22, 2019, subject to Mr. Gordon's continuous service as of each such date; F7: (iv) 41,084 RSUs granted on July 25, 2018, which shall be settled into common stock pursuant to the following vesting schedule: 25% of the RSUs shall vest on July 25, 2019, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Gordon's continuous service as of each such date; and (v) 5,870 RSUs granted on October 12, 2018 which shall be settled into common stock pursuant to the following vesting schedule: 25% of the RSUs shall vest on August 14, 2019, with the remaining 75% of such RSUs vesting in 36 equal monthly installments thereafter, subject to Mr. Gordon's continuous service as of each such date. |
| Common StockSEC Table I · non-derivative | Direct | 162,265 |
Reported balance
After 2019-02-22 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2019-02-22 · Sale · Disposed 438 · Balance 162,265 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2018. F8: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.91 to $18.25, inclusive. The reporting person undertakes to provide to Liquidia Technologies, Inc., any holder of Liquidia Technologies, Inc. stock or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 8 to this Form 4. F9: Includes (i) 1,714 former RSUs which settled into common stock on February 22, 2019 on a net basis following the sales of an aggregate of 943 shares of common stock (inclusive of the 293 shares which were sold as described in footnotes 3 and 4 and the 212 shares which were sold as described in footnotes 6 and 7) to cover estimated taxes, transaction costs and fees associated with the vesting event, (ii) 20,572 former RSUs which settled into common stock on January 22, 2019 on a net basis following the sales of an aggregate of 11,322 shares of common stock to cover estimated taxes, transaction costs and fees associated with the vesting event, (iii) 93,025 remaining RSUs granted on January 22, 2018, which shall be settled into common stock in 36 equal monthly installments commencing January 22, 2019, subject to Mr. Gordon's continuous service as of each such date; F10: (iv) 41,084 RSUs granted on July 25, 2018, which shall be settled into common stock pursuant to the following vesting schedule: 25% of the RSUs shall vest on July 25, 2019, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Gordon's continuous service as of each such date; and (v) 5,870 RSUs granted on October 12, 2018 which shall be settled into common stock pursuant to the following vesting schedule: 25% of the RSUs shall vest on August 14, 2019, with the remaining 75% of such RSUs vesting in 36 equal monthly installments thereafter, subject to Mr. Gordon's continuous service as of each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2018.
F2: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.52 to $16.21, inclusive. The reporting person undertakes to provide to Liquidia Technologies, Inc., any holder of Liquidia Technologies, Inc. stock or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4.
F3: Includes (i) 2,364 former restricted stock units ("RSUs") which settled into common stock on February 22, 2019 on a net basis following the sales of an aggregate of 293 shares of common stock to cover estimated taxes, transaction costs and fees associated with the vesting event, (ii) 20,572 former RSUs which settled into common stock on January 22, 2019 on a net basis following the sales of an aggregate of 11,322 shares of common stock to cover estimated taxes, transaction costs and fees associated with the vesting event, (iii) 93,025 remaining RSUs granted on January 22, 2018, which shall be settled into common stock in 36 equal monthly installments commencing January 22, 2019, subject to Mr. Gordon's continuous service as of each such date;
F4: (iv) 41,084 RSUs granted on July 25, 2018, which shall be settled into common stock pursuant to the following vesting schedule: 25% of the RSUs shall vest on July 25, 2019, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Gordon's continuous service as of each such date; and (v) 5,870 RSUs granted on October 12, 2018 which shall be settled into common stock pursuant to the following vesting schedule: 25% of the RSUs shall vest on August 14, 2019, with the remaining 75% of such RSUs vesting in 36 equal monthly installments thereafter, subject to Mr. Gordon's continuous service as of each such date.
F5: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.82 to $16.84, inclusive. The reporting person undertakes to provide to Liquidia Technologies, Inc., any holder of Liquidia Technologies, Inc. stock or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 5 to this Form 4.
F6: Includes (i) 2,152 former RSUs which settled into common stock on February 22, 2019 on a net basis following the sales of an aggregate of 505 shares of common stock (inclusive of the 293 shares which were sold as described in footnotes 3 and 4) to cover estimated taxes, transaction costs and fees associated with the vesting event, (ii) 20,572 former RSUs which settled into common stock on January 22, 2019 on a net basis following the sales of an aggregate of 11,322 shares of common stock to cover estimated taxes, transaction costs and fees associated with the vesting event, (iii) 93,025 remaining RSUs granted on January 22, 2018, which shall be settled into common stock in 36 equal monthly installments commencing January 22, 2019, subject to Mr. Gordon's continuous service as of each such date;
F7: (iv) 41,084 RSUs granted on July 25, 2018, which shall be settled into common stock pursuant to the following vesting schedule: 25% of the RSUs shall vest on July 25, 2019, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Gordon's continuous service as of each such date; and (v) 5,870 RSUs granted on October 12, 2018 which shall be settled into common stock pursuant to the following vesting schedule: 25% of the RSUs shall vest on August 14, 2019, with the remaining 75% of such RSUs vesting in 36 equal monthly installments thereafter, subject to Mr. Gordon's continuous service as of each such date.
F8: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.91 to $18.25, inclusive. The reporting person undertakes to provide to Liquidia Technologies, Inc., any holder of Liquidia Technologies, Inc. stock or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 8 to this Form 4.
F9: Includes (i) 1,714 former RSUs which settled into common stock on February 22, 2019 on a net basis following the sales of an aggregate of 943 shares of common stock (inclusive of the 293 shares which were sold as described in footnotes 3 and 4 and the 212 shares which were sold as described in footnotes 6 and 7) to cover estimated taxes, transaction costs and fees associated with the vesting event, (ii) 20,572 former RSUs which settled into common stock on January 22, 2019 on a net basis following the sales of an aggregate of 11,322 shares of common stock to cover estimated taxes, transaction costs and fees associated with the vesting event, (iii) 93,025 remaining RSUs granted on January 22, 2018, which shall be settled into common stock in 36 equal monthly installments commencing January 22, 2019, subject to Mr. Gordon's continuous service as of each such date;
F10: (iv) 41,084 RSUs granted on July 25, 2018, which shall be settled into common stock pursuant to the following vesting schedule: 25% of the RSUs shall vest on July 25, 2019, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Gordon's continuous service as of each such date; and (v) 5,870 RSUs granted on October 12, 2018 which shall be settled into common stock pursuant to the following vesting schedule: 25% of the RSUs shall vest on August 14, 2019, with the remaining 75% of such RSUs vesting in 36 equal monthly installments thereafter, subject to Mr. Gordon's continuous service as of each such date.
Progyny, Inc.
Report date September 10, 2026 · Filed September 18, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,792 |
Last balance in matching sequence
After 2026-09-10 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2026-09-10 · Exercise / conversion · Acquired 22,000 · Balance 28,792 Row 2 · 2026-09-10 · Tax withholding · Disposed 10,500 · Balance 18,292 Row 3 · 2026-09-10 · Sale · Disposed 11,500 · Balance 6,792 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.99 to $27.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote F2: This Form 4 is being filed to correct a clerical error in a previously filed Form 4. The weighted average for the transaction was inadvertently reported as $27.9442 instead of $27.1181. All other information previously reported remains unchanged. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.00 · Expires 2029-10-11 | Direct | 22,000 |
Reported balance
After 2026-09-10 transaction · row 4
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 4 · 2026-09-10 · Exercise / conversion · Disposed 22,000 · Balance 22,000 F3: The shares are fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.99 to $27.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
F2: This Form 4 is being filed to correct a clerical error in a previously filed Form 4. The weighted average for the transaction was inadvertently reported as $27.9442 instead of $27.1181. All other information previously reported remains unchanged.
F3: The shares are fully vested.
VERACYTE, INC.
Report date June 08, 2022 · Filed June 10, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,720 |
Ending reported balance
After 2022-06-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-06-08 · Exercise / conversion · Acquired 15,000 · Balance 23,720 Row 2 · 2022-06-08 · Sale · Disposed 15,000 · Balance 8,720 F1: Represents weighted average sales price. Sale prices for the transactions range from $18.00 to $18.01. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.39 · Expires 2026-12-11 | Direct | 0 |
Reported balance
After 2022-06-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-06-08 · Exercise / conversion · Disposed 15,000 · Balance 0 F2: The option is fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents weighted average sales price. Sale prices for the transactions range from $18.00 to $18.01. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F2: The option is fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 25, 2018 Filed Jul 27, 2018 21:02 UTC | Liquidia Technologies Inc LQDA · Entity 145051 | GrantRestricted Stock UnitA · Derivative | 41,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-047752 · a4.xml · derivative · entry 2 GORDON KEVIN K · CIK 0001218483 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,660 Underlying: Common Stock · 41,084 shares Expires 2028-07-24 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: 25% of such restricted stock units vest on July 25, 2019, with the remainder vesting in 36 equal monthly installments after July 25, 2019, subject to Mr. Gordon's continuous service as of each such date. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 21:02 UTC | Liquidia Technologies Inc LQDA · Entity 145051 | GrantStock Option · Derivative | 41,084 | $0.00 Strike: $11.00 | $0.00 |
DisclosureSEC source: 0001104659-18-047752 · a4.xml · derivative · entry 1 GORDON KEVIN K · CIK 0001218483 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,084 Underlying: Common Stock · 41,084 shares Expires 2028-07-25 F1 · derivative.exercise_date: 25% of such options vest on July 25, 2019, with the remainder vesting in 36 equal monthly installments after July 25, 2019, subject to Mr. Gordon's continuous service as of each such date. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 21:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.60 | $0.00 |
DisclosureSEC source: 0001384101-18-000044 · wf-form4_152840624960204.xml · derivative · entry 1 GORDON KEVIN K · CIK 0001218483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-06-07 F1 · derivative.exercise_date: The option becomes exercisable in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 07, 2017 Filed Jun 7, 2017 21:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001384101-17-000036 · wf-form4_149687025737082.xml · derivative · entry 1 GORDON KEVIN K · CIK 0001218483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-06-07 F1 · derivative.exercise_date: The option becomes exercisable in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 22:11 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $7.39 | $0.00 |
DisclosureSEC source: 0001384101-16-000012 · wf-form4_148166707464385.xml · derivative · entry 1 GORDON KEVIN K · CIK 0001218483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2026-12-11 F1 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on December 12, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.